Experienced in Ataxia-Telangiectasia
Experienced in Ataxia-Telangiectasia
301 Yanchang Zhong Rd, 
Shanghai, CN 

Overview

Bo Zhang practices in Shanghai, China. Mr. Zhang is rated as an Experienced expert by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Gastrointestinal Stromal Tumor, Stomach Cancer, Gallstones, Gastrectomy, and Pancreaticoduodenectomy.

His clinical research consists of co-authoring 227 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Ataxia-Telangiectasia.

Gender
Male

Locations

301 Yanchang Zhong Rd, Shanghai, 200072, China
Other Locations
State Key Laboratory Of Oral Diseases &National Clinical Research Center For Oral Diseases, Chengdu, China
68 West Jiyang Road, Zhangjiadun, 215600, China
Fudan University 180 Feng Lin Road, Zhongshan, 200032, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


227 Total Publications

Intraperitoneal chemotherapy for gastric cancer.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Zhang's expertise for a condition
ConditionClose
    View All 38 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile